Antipsychotics: is it time to introduce patient choice?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 22859572.
- Also identified by DOI 10.1192/bjp.bp.112.112110.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Evidence regarding overestimation of the efficacy of antipsychotics and underestimation of their toxicity, as well as emerging data regarding alternative treatment options, suggests it may be time to introduce patient choice and reconsider whether everyone who meets the criteria for a schizophrenia spectrum diagnosis requires antipsychotics in order to recover.
Medical subject headings
- Antipsychotic Agents
- Choice Behavior
- Schizophrenia